{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:03:34Z","timestamp":1789452214865,"version":"build-2803163510"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["1008910"],"award-info":[{"award-number":["1008910"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s11064-015-1665-3","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T11:35:11Z","timestamp":1437564911000},"page":"544-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis"],"prefix":"10.1007","volume":"41","author":[{"given":"Nirma D.","family":"Perera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"1665_CR1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrn3430","volume":"14","author":"W Robberecht","year":"2013","unstructured":"Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14:248\u2013264","journal-title":"Nat Rev Neurosci"},{"key":"1665_CR2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M Belanger","year":"2011","unstructured":"Belanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14:724\u2013738","journal-title":"Cell Metab"},{"key":"1665_CR3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","volume":"75","author":"JJ Harris","year":"2012","unstructured":"Harris JJ, Jolivet R, Attwell D (2012) Synaptic energy use and supply. Neuron 75:762\u2013777","journal-title":"Neuron"},{"key":"1665_CR4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/jcbfm.2013.128","volume":"33","author":"P Schonfeld","year":"2013","unstructured":"Schonfeld P, Reiser G (2013) Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J Cereb Blood Flow Metab 33:1493\u20131499","journal-title":"J Cereb Blood Flow Metab"},{"key":"1665_CR5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/jcbfm.2009.35","volume":"29","author":"G Hall van","year":"2009","unstructured":"van Hall G, Stromstad M, Rasmussen P, Jans O, Zaar M, Gam C, Quistorff B, Secher NH, Nielsen HB (2009) Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab 29:1121\u20131129","journal-title":"J Cereb Blood Flow Metab"},{"key":"1665_CR6","first-page":"657","volume-title":"Psychopharmacology: the fourth generation of progress","author":"PJ Magistretti","year":"1995","unstructured":"Magistretti PJ, Pellerin L, Martin JL (1995) Brain energy metabolism: an integrated cellular perspective. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 657\u2013670"},{"key":"1665_CR7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/jcbfm.2011.149","volume":"32","author":"L Pellerin","year":"2012","unstructured":"Pellerin L, Magistretti PJ (2012) Sweet sixteen for ANLS. J Cereb Blood Flow Metab 32:1152\u20131166","journal-title":"J Cereb Blood Flow Metab"},{"key":"1665_CR8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/01.WCB.0000091761.61714.25","volume":"23","author":"A-K Bouzier-Sore","year":"2003","unstructured":"Bouzier-Sore A-K, Voisin P, Canioni P, Magistretti PJ, Pellerin L (2003) Lactate is a preferential oxidative energy substrate over glucose for neurons in culture. J Cereb Blood Flow Metab 23:1298\u20131306","journal-title":"J Cereb Blood Flow Metab"},{"key":"1665_CR9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/01.WCB.0000063991.19746.11","volume":"23","author":"D Smith","year":"2003","unstructured":"Smith D, Pernet A, Hallett WA, Bingham E, Marsden PK, Amiel SA (2003) Lactate: a preferred fuel for human brain metabolism in vivo. J cereb Blood Flow Metab 23:658\u2013664","journal-title":"J cereb Blood Flow Metab"},{"key":"1665_CR10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00004647-199611000-00001","volume":"16","author":"PG Bittar","year":"1996","unstructured":"Bittar PG, Charnay Y, Pellerin L, Bouras C, Magistretti PJ (1996) Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain. J Cereb Blood Flow Metab 16:1079\u20131089","journal-title":"J Cereb Blood Flow Metab"},{"key":"1665_CR11","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1172\/JCI63967","volume":"122","author":"DW Foster","year":"2012","unstructured":"Foster DW (2012) Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J Clin Investig 122:1958\u20131959","journal-title":"J Clin Investig"},{"key":"1665_CR12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1471-4159.2010.07103.x","volume":"117","author":"RW Mitchell","year":"2011","unstructured":"Mitchell RW, On NH, Del Bigio MR, Miller DW, Hatch GM (2011) Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells. J Neurochem 117:735\u2013746","journal-title":"J Neurochem"},{"key":"1665_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","volume":"26","author":"GF Cahill Jr","year":"2006","unstructured":"Cahill GF Jr (2006) Fuel metabolism in starvation. Annu Rev Nutr 26:1\u201322","journal-title":"Annu Rev Nutr"},{"key":"1665_CR14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13:251\u2013262","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1665_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1748-1716.2009.01977.x","volume":"196","author":"JS Oakhill","year":"2009","unstructured":"Oakhill JS, Scott JW, Kemp BE (2009) Structure and function of AMP-activated protein kinase. Acta Physiol (Oxford, England) 196:3\u201314","journal-title":"Acta Physiol (Oxford, England)"},{"key":"1665_CR16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/jcbfm.2009.255","volume":"30","author":"J Li","year":"2010","unstructured":"Li J, McCullough LD (2010) Effects of AMP-activated protein kinase in cerebral ischemia. J Cereb Blood Flow Metab 30:480\u2013492","journal-title":"J Cereb Blood Flow Metab"},{"key":"1665_CR17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1523\/JNEUROSCI.6554-10.2012","volume":"32","author":"MA Lim","year":"2012","unstructured":"Lim MA, Selak MA, Xiang Z, Krainc D, Neve RL, Kraemer BC, Watts JL, Kalb RG (2012) Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease. J Neurosci 32:1123\u20131141","journal-title":"J Neurosci"},{"key":"1665_CR18","unstructured":"Ofir M, Hochhauser E, Vidne BA, Freimark D, Arad M (2007) AMP-activated protein kinase: how a mistake in energy gauge causes glycogen storage. Harefuah 146:770\u2013775, 813\u2013814"},{"issue":"Suppl 1","key":"1665_CR19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2009.05916.x","volume":"109","author":"GV Ronnett","year":"2009","unstructured":"Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S (2009) AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem 109(Suppl 1):17\u201323","journal-title":"J Neurochem"},{"key":"1665_CR20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/bies.200900003","volume":"31","author":"J Poels","year":"2009","unstructured":"Poels J, Spasic MR, Callaerts P, Norga KK (2009) Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy. BioEssays 31:944\u2013952","journal-title":"BioEssays"},{"key":"1665_CR21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.59.5.773","volume":"59","author":"N Scarmeas","year":"2002","unstructured":"Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP (2002) Premorbid weight, body mass, and varsity athletics in ALS. Neurology 59:773\u2013775","journal-title":"Neurology"},{"key":"1665_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2008.12.027","volume":"279","author":"N Vaisman","year":"2009","unstructured":"Vaisman N, Lusaus M, Nefussy B, Niv E, Comaneshter D, Hallack R, Drory VE (2009) Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J Neurol Sci 279:26\u201329","journal-title":"J Neurol Sci"},{"key":"1665_CR23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","volume":"74","author":"JC Desport","year":"2001","unstructured":"Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, Couratier P (2001) Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 74:328\u2013334","journal-title":"Am J Clin Nutr"},{"key":"1665_CR24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.53.5.1059","volume":"53","author":"JC Desport","year":"1999","unstructured":"Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P (1999) Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53:1059\u20131063","journal-title":"Neurology"},{"key":"1665_CR25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/17482968.2010.482592","volume":"11","author":"A Jawaid","year":"2010","unstructured":"Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, Simpson E, Harati Y, Strutt AM, York MK, Schulz PE (2010) A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler 11:542\u2013548","journal-title":"Amyotroph Lateral Scler"},{"key":"1665_CR26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ajcn\/63.1.130","volume":"63","author":"EJ Kasarskis","year":"1996","unstructured":"Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ (1996) Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 63:130\u2013137","journal-title":"Am J Clin Nutr"},{"key":"1665_CR27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00415-009-5100-z","volume":"256","author":"C Bouteloup","year":"2009","unstructured":"Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256:1236\u20131242","journal-title":"J Neurol"},{"key":"1665_CR28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","volume":"10","author":"L Dupuis","year":"2011","unstructured":"Dupuis L, Pradat P-F, Ludolph AC, Loeffler J-P (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10:75\u201382","journal-title":"Lancet Neurol"},{"key":"1665_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/21678421.2012.735240","volume":"14","author":"EJ O\u2019Reilly","year":"2013","unstructured":"O\u2019Reilly EJ, Wang H, Weisskopf MG, Fitzgerald KC, Falcone G, McCullough ML, Thun M, Park Y, Kolonel LN, Ascherio A (2013) Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14:205\u2013211","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1665_CR30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000089626","volume":"2","author":"J-C Desport","year":"2005","unstructured":"Desport J-C, Torny F, Lacoste M, Preux P-M, Couratier P (2005) Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neuro Degener Dis 2:202\u2013207","journal-title":"Neuro Degener Dis"},{"key":"1665_CR31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.16.5.475","volume":"16","author":"AK Afifi","year":"1966","unstructured":"Afifi AK, Aleu FP, Goodgold J, MacKay B (1966) Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis. Neurology 16:475\u2013481","journal-title":"Neurology"},{"key":"1665_CR32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00691318","volume":"55","author":"T Atsumi","year":"1981","unstructured":"Atsumi T (1981) The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis. Acta Neuropathol 55:193\u2013198","journal-title":"Acta Neuropathol"},{"key":"1665_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(96)12314-4","volume":"204","author":"S Sasaki","year":"1996","unstructured":"Sasaki S, Iwata M (1996) Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett 204:53\u201356","journal-title":"Neurosci Lett"},{"key":"1665_CR34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.410390210","volume":"39","author":"L Siklos","year":"1996","unstructured":"Siklos L, Engelhardt J, Harati Y, Smith RG, Joo F, Appel SH (1996) Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann Neurol 39:203\u2013216","journal-title":"Ann Neurol"},{"key":"1665_CR35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8","volume":"46","author":"GM Borthwick","year":"1999","unstructured":"Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM (1999) Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann neurol 46:787\u2013790","journal-title":"Ann neurol"},{"key":"1665_CR36","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.1993.tb07478.x","volume":"61","author":"AC Bowling","year":"1993","unstructured":"Bowling AC, Schulz JB, Brown RH Jr, Beal MF (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61:2322\u20132325","journal-title":"J Neurochem"},{"key":"1665_CR37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1097-4547(19960801)45:3<276::AID-JNR9>3.0.CO;2-A","volume":"45","author":"K Fujita","year":"1996","unstructured":"Fujita K, Yamauchi M, Shibayama K, Ando M, Honda M, Nagata Y (1996) Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis. J Neurosci Res 45:276\u2013281","journal-title":"J Neurosci Res"},{"key":"1665_CR38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-510X(98)00008-2","volume":"156","author":"FR Wiedemann","year":"1998","unstructured":"Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, Kunz WS (1998) Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 156:65\u201372","journal-title":"J Neurol Sci"},{"key":"1665_CR39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2005.07.020","volume":"198","author":"A Echaniz-Laguna","year":"2006","unstructured":"Echaniz-Laguna A, Zoll J, Ponsot E, N\u2019Guessan B, Tranchant C, Loeffler J-P, Lampert E (2006) Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp Neurol 198:25\u201330","journal-title":"Exp Neurol"},{"key":"1665_CR40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/507423a","volume":"507","author":"S Perrin","year":"2014","unstructured":"Perrin S (2014) Preclinical research: make mouse studies work. Nature 507:423\u2013425","journal-title":"Nature"},{"key":"1665_CR41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1979.00500400071011","volume":"36","author":"Y Nagano","year":"1979","unstructured":"Nagano Y, Tsubaki T, Chase TN (1979) Endocrinologic regulation of carbohydrate metabolism. Amyotrophic lateral sclerosis and parkinsonism-dementia on guam. Arch Neurol 36:217\u2013220","journal-title":"Arch Neurol"},{"key":"1665_CR42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/17482960902822960","volume":"11","author":"P-F Pradat","year":"2010","unstructured":"Pradat P-F, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, Salachas F, Corcia P, Frochot V, Lacorte J-M, Jardel C, Coussieu C, Le Forestier N, Lacomblez L, Loeffler J-P, Meininger V (2010) Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11:166\u2013171","journal-title":"Amyotroph Lateral Scler"},{"key":"1665_CR43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0022-510X(84)90154-0","volume":"63","author":"ET Reyes","year":"1984","unstructured":"Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV (1984) Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci 63:317\u2013324","journal-title":"J Neurol Sci"},{"key":"1665_CR44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biopha.2005.03.003","volume":"59","author":"J-L Gonzalez de Aguilar","year":"2005","unstructured":"Gonzalez de Aguilar J-L, Dupuis L, Oudart H, Loeffler J-P (2005) The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu\/Zn-superoxide dismutase mice. Biomed Pharmacother 59:190\u2013196","journal-title":"Biomed Pharmacother"},{"key":"1665_CR45","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.410220504","volume":"22","author":"MC Dalakas","year":"1987","unstructured":"Dalakas MC, Hatazawa J, Brooks RA, Di Chiro G (1987) Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann neurol 22:580\u2013586","journal-title":"Ann neurol"},{"key":"1665_CR46","doi-asserted-by":"crossref","first-page":"10812","DOI":"10.1073\/pnas.1308421110","volume":"110","author":"JC Dodge","year":"2013","unstructured":"Dodge JC, Treleaven CM, Fidler JA, Tamsett TJ, Bao C, Searles M, Taksir TV, Misra K, Sidman RL, Cheng SH, Shihabuddin LS (2013) Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc Natl Acad Sci USA 110:10812\u201310817","journal-title":"Proc Natl Acad Sci USA"},{"key":"1665_CR47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1620\/tjem.139.365","volume":"139","author":"A Murai","year":"1983","unstructured":"Murai A, Miyahara T, Tanaka T, Kaneko T, Sako Y, Kameyama M (1983) Abnormalities of lipoprotein and carbohydrate metabolism in degenerative diseases of the nervous system\u2014motor neuron disease and spinocerebellar degeneration. Tohoku J Exp Med 139:365\u2013376","journal-title":"Tohoku J Exp Med"},{"key":"1665_CR48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1468-1331.2009.02923.x","volume":"17","author":"A Jawaid","year":"2010","unstructured":"Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, Simpson E, Appel SH, York MK, Schulz PE (2010) ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol 17:733\u2013739","journal-title":"Eur J Neurol"},{"key":"1665_CR49","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, Meininger V (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70:1004\u20131009","journal-title":"Neurology"},{"key":"1665_CR50","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","volume":"258","author":"J Dorst","year":"2011","unstructured":"Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 258:613\u2013617","journal-title":"J Neurol"},{"key":"1665_CR51","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/brain\/awh373","volume":"128","author":"A Chio","year":"2005","unstructured":"Chio A, Benzi G, Dossena M, Mutani R, Mora G (2005) Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128:472\u2013476","journal-title":"Brain"},{"key":"1665_CR52","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1212\/WNL.58.7.1112","volume":"58","author":"L Lacomblez","year":"2002","unstructured":"Lacomblez L, Doppler V, Beucler I, Costes G, Salachas F, Raisonnier A, Le Forestier N, Pradat PF, Bruckert E, Meininger V (2002) APOE: a potential marker of disease progression in ALS. Neurology 58:1112\u20131114","journal-title":"Neurology"},{"key":"1665_CR53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/17482960802031092","volume":"9","author":"L Zinman","year":"2008","unstructured":"Zinman L, Sadeghi R, Gawel M, Patton D, Kiss A (2008) Are statin medications safe in patients with ALS? Amyotroph Lateral Scler 9:223\u2013228","journal-title":"Amyotroph Lateral Scler"},{"key":"1665_CR54","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/pds.1643","volume":"17","author":"E Colman","year":"2008","unstructured":"Colman E, Szarfman A, Wyeth J, Mosholder A, Jillapalli D, Levine J, Avigan M (2008) An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA\u2019s spontaneous adverse event reporting system. Pharmacoepidemiol Drug Saf 17:1068\u20131076","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1665_CR55","doi-asserted-by":"crossref","first-page":"e67783","DOI":"10.1371\/journal.pone.0067783","volume":"8","author":"E Lindauer","year":"2013","unstructured":"Lindauer E, Dupuis L, M\u00fcller HP, Neumann H, Ludolph AC, Kassubek J (2013) Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS One 8:e67783","journal-title":"PLoS One"},{"key":"1665_CR56","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2337\/db11-1300","volume":"61","author":"N Barzilai","year":"2012","unstructured":"Barzilai N, Huffman DM, Muzumdar RH, Bartke A (2012) The critical role of metabolic pathways in aging. Diabetes 61:1315\u20131322","journal-title":"Diabetes"},{"key":"1665_CR57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1212\/WNL.26.2.167","volume":"26","author":"MT Felmus","year":"1976","unstructured":"Felmus MT, Patten BM, Swanke L (1976) Antecedent events in amyotrophic lateral sclerosis. Neurology 26:167\u2013172","journal-title":"Neurology"},{"key":"1665_CR58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0404.1996.tb00038.x","volume":"94","author":"D Strickland","year":"1996","unstructured":"Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI (1996) Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand 94:45\u201350","journal-title":"Acta Neurol Scand"},{"key":"1665_CR59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/01.WNL.0000149513.82332.5C","volume":"64","author":"JH Veldink","year":"2005","unstructured":"Veldink JH, Kalmijn S, Groeneveld GJ, Titulaer MJ, Wokke JHJ, van den Berg LH (2005) Physical activity and the association with sporadic ALS. Neurology 64:241\u2013245","journal-title":"Neurology"},{"key":"1665_CR60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2007.06.021","volume":"262","author":"C Armon","year":"2007","unstructured":"Armon C (2007) Sports and trauma in amyotrophic lateral sclerosis revisited. J Neurol Sci 262:45\u201353","journal-title":"J Neurol Sci"},{"key":"1665_CR61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0306-9877(91)90183-Y","volume":"34","author":"WT Longstreth","year":"1991","unstructured":"Longstreth WT, Nelson LM, Koepsell TD, van Belle G (1991) Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Med Hypotheses 34:144\u2013148","journal-title":"Med Hypotheses"},{"key":"1665_CR62","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/01.wnl.0000264418.92308.a4","volume":"68","author":"VD Bello-Haas","year":"2007","unstructured":"Bello-Haas VD, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, Pioro EP, Mitsumoto H (2007) A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 68:2003\u20132007","journal-title":"Neurology"},{"key":"1665_CR63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(01)00610-4","volume":"191","author":"VE Drory","year":"2001","unstructured":"Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD (2001) The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 191:133\u2013137","journal-title":"J Neurol Sci"},{"key":"1665_CR64","author":"M Vergouts","year":"2015","unstructured":"Vergouts M, Marinangeli C, Ingelbrecht C, Genard G, Schakman O, Sternotte A, Calas A, Hermans E (2015) Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease. Metab Brain Dis. doi: 10.1007\/s11011-015-9706-9","journal-title":"Metab Brain Dis"},{"key":"1665_CR65","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/cdd.2012.158","volume":"20","author":"AT Behan","year":"2013","unstructured":"Behan AT, Breen B, Hogg M, Woods I, Coughlan K, Mitchem M, Prehn JH (2013) Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration. Cell Death Differ 20:589\u2013598","journal-title":"Cell Death Differ"},{"key":"1665_CR66","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1093\/hmg\/ddu214","volume":"23","author":"MA Lim","year":"2014","unstructured":"Lim MA, Bence KK, Sandesara I, Andreux P, Auwerx J, Ishibashi J, Seale P, Kalb RG (2014) Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet 23:4995\u20135008","journal-title":"Hum Mol Genet"},{"key":"1665_CR67","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/hmg\/ddt202","volume":"22","author":"J Eschbach","year":"2013","unstructured":"Eschbach J, Schwalenstocker B, Soyal SM, Bayer H, Wiesner D, Akimoto C, Nilsson A-C, Birve A, Meyer T, Dupuis L, Danzer KM, Andersen PM, Witting A, Ludolph AC, Patsch W, Weydt P (2013) PGC-1alpha is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis. Hum Mol Genet 22:3477\u20133484","journal-title":"Hum Mol Genet"},{"key":"1665_CR68","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.22217","volume":"44","author":"H Liang","year":"2011","unstructured":"Liang H, Ward WF, Jang YC, Bhattacharya A, Bokov AF, Li Y, Jernigan A, Richardson A, Van Remmen H (2011) PGC-1alpha protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model. Muscle Nerve 44:947\u2013956","journal-title":"Muscle Nerve"},{"key":"1665_CR69","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cmet.2012.03.019","volume":"15","author":"S Cruz Da","year":"2012","unstructured":"Da Cruz S, Parone PA, Lopes VS, Lillo C, McAlonis-Downes M, Lee SK, Vetto AP, Petrosyan S, Marsala M, Murphy AN, Williams DS, Spiegelman BM, Cleveland DW (2012) Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab 15:778\u2013786","journal-title":"Cell Metab"},{"key":"1665_CR70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1326-6-51","volume":"6","author":"W Zhao","year":"2011","unstructured":"Zhao W, Varghese M, Yemul S, Pan Y, Cheng A, Marano P, Hassan S, Vempati P, Chen F, Qian X, Pasinetti GM (2011) Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1alpha) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. Mol Neurodegener 6:51","journal-title":"Mol Neurodegener"},{"key":"1665_CR71","doi-asserted-by":"crossref","first-page":"e5390","DOI":"10.1371\/journal.pone.0005390","volume":"4","author":"L Dupuis","year":"2009","unstructured":"Dupuis L, Gonzalez de Aguilar JL, Echaniz-Laguna A, Eschbach J, Rene F, Oudart H, Halter B, Huze C, Schaeffer L, Bouillaud F, Loeffler JP (2009) Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One 4:e5390","journal-title":"PLoS One"},{"key":"1665_CR72","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mcn.2013.10.002","volume":"57","author":"PM Peixoto","year":"2013","unstructured":"Peixoto PM, Kim H-J, Sider B, Starkov A, Horvath TL, Manfredi G (2013) UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis. Mol Cell Neurosci 57:104\u2013110","journal-title":"Mol Cell Neurosci"},{"key":"1665_CR73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-8993(99)01471-7","volume":"833","author":"WA Pedersen","year":"1999","unstructured":"Pedersen WA, Mattson MP (1999) No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu\/Zn-superoxide dismutase mutant mice. Brain Res 833:117\u2013120","journal-title":"Brain Res"},{"key":"1665_CR74","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mus.20255","volume":"31","author":"MJ Hamadeh","year":"2005","unstructured":"Hamadeh MJ, Rodriguez MC, Kaczor JJ, Tarnopolsky MA (2005) Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu\/Zn-superoxide dismutase mutant G93A mouse. Muscle Nerve 31:214\u2013220","journal-title":"Muscle Nerve"},{"key":"1665_CR75","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mus.20630","volume":"34","author":"MJ Hamadeh","year":"2006","unstructured":"Hamadeh MJ, Tarnopolsky MA (2006) Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu\/Zn-SOD mutant G93A mice. Muscle Nerve 34:709\u2013719","journal-title":"Muscle Nerve"},{"key":"1665_CR76","doi-asserted-by":"crossref","first-page":"e9386","DOI":"10.1371\/journal.pone.0009386","volume":"5","author":"BP Patel","year":"2010","unstructured":"Patel BP, Safdar A, Raha S, Tarnopolsky MA, Hamadeh MJ (2010) Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS. PLoS One 5:e9386","journal-title":"PLoS One"},{"key":"1665_CR77","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.neurobiolaging.2011.06.002","volume":"33","author":"A Bhattacharya","year":"2012","unstructured":"Bhattacharya A, Bokov A, Muller FL, Jernigan AL, Maslin K, Diaz V, Richardson A, Van Remmen H (2012) Dietary restriction but not rapamycin extends disease onset and survival of the H46R\/H48Q mouse model of ALS. Neurobiol Aging 33:1829\u20131832","journal-title":"Neurobiol Aging"},{"key":"1665_CR78","doi-asserted-by":"crossref","first-page":"e49191","DOI":"10.1371\/journal.pone.0049191","volume":"7","author":"W Zhao","year":"2012","unstructured":"Zhao W, Varghese M, Vempati P, Dzhun A, Cheng A, Wang J, Lange D, Bilski A, Faravelli I, Pasinetti GM (2012) Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS One 7:e49191","journal-title":"PLoS One"},{"key":"1665_CR79","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","volume":"5","author":"P Klivenyi","year":"1999","unstructured":"Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5:347\u2013350","journal-title":"Nat Med"},{"key":"1665_CR80","doi-asserted-by":"crossref","first-page":"e103526","DOI":"10.1371\/journal.pone.0103526","volume":"9","author":"C Ari","year":"2014","unstructured":"Ari C, Poff AM, Held HE, Landon CS, Goldhagen CR, Mavromates N, D\u2019Agostino DP (2014) Metabolic therapy with Deanna protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model. PLoS One 9:e103526","journal-title":"PLoS One"},{"key":"1665_CR81","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1124\/jpet.105.092312","volume":"316","author":"R Danzeisen","year":"2006","unstructured":"Danzeisen R, Schwalenstoecker B, Gillardon F, Buerger E, Krzykalla V, Klinder K, Schild L, Hengerer B, Ludolph AC, Dorner-Ciossek C, Kussmaul L (2006) Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x (+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride. J Pharmacol Exp Ther 316:189\u2013199","journal-title":"J Pharmacol Exp Ther"},{"key":"1665_CR82","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.2174\/0929867321666140601162710","volume":"21","author":"G Yacila","year":"2014","unstructured":"Yacila G, Sari Y (2014) Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis. Curr Med Chem 21:3583\u20133593","journal-title":"Curr Med Chem"},{"key":"1665_CR83","doi-asserted-by":"crossref","first-page":"526","DOI":"10.15252\/emmm.201404433","volume":"7","author":"L Palamiuc","year":"2015","unstructured":"Palamiuc L, Schlagowski A, Ngo ST, Vernay A, Dirrig-Grosch S, Henriques A, Boutillier A-L, Zoll J, Echaniz-Laguna A, Loeffler J-P, Rene F (2015) A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol Med 7:526\u2013546","journal-title":"EMBO Mol Med"},{"key":"1665_CR84","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1073\/pnas.0402026101","volume":"101","author":"L Dupuis","year":"2004","unstructured":"Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar J-L, Loeffler J-P (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 101:11159\u201311164","journal-title":"Proc Natl Acad Sci USA"},{"key":"1665_CR85","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2202-7-29","volume":"7","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J, Pasinetti GM (2006) A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 7:29","journal-title":"BMC Neurosci"},{"key":"1665_CR86","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.neurobiolaging.2014.09.022","volume":"36","author":"KS Coughlan","year":"2015","unstructured":"Coughlan KS, Mitchem MR, Hogg MC, Prehn JH (2015) \u201cPreconditioning\u201d with latrepirdine, an adenosine 5\u2032-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice. Neurobiol Aging 36:1140\u20131150","journal-title":"Neurobiol Aging"},{"key":"1665_CR87","doi-asserted-by":"crossref","first-page":"e24189","DOI":"10.1371\/journal.pone.0024189","volume":"6","author":"HM Kaneb","year":"2011","unstructured":"Kaneb HM, Sharp PS, Rahmani-Kondori N, Wells DJ (2011) Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice. PLoS One 6:e24189","journal-title":"PLoS One"},{"key":"1665_CR88","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/17482968.2012.662988","volume":"13","author":"J Li","year":"2012","unstructured":"Li J, Paulson JM, Ye FD, Sung M, Hollenberg AN, Rutkove SB (2012) Reducing systemic hypermetabolism by inducing hypothyroidism does not prolong survival in the SOD1-G93A mouse. Amyotroph Lateral Scler 13:372\u2013377","journal-title":"Amyotroph Lateral Scler"},{"key":"1665_CR89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neulet.2006.11.058","volume":"413","author":"J-H Park","year":"2007","unstructured":"Park J-H, Hong Y-H, Kim H-J, Kim S-M, Kim M-J, Park K-S, Sung J-J, Lee K-W (2007) Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model. Neurosci Lett 413:265\u2013269","journal-title":"Neurosci Lett"},{"key":"1665_CR90","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2007.06.095","volume":"1168","author":"E Esposito","year":"2007","unstructured":"Esposito E, Capasso M, di Tomasso N, Corona C, Pellegrini F, Uncini A, Vitaglione P, Fogliano V, Piantelli M, Sensi SL (2007) Antioxidant strategies based on tomato-enriched food or pyruvate do not affect disease onset and survival in an animal model of amyotrophic lateral sclerosis. Brain Res 1168:90\u201396","journal-title":"Brain Res"},{"key":"1665_CR91","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/17482968.2010.491867","volume":"11","author":"DJ Amante","year":"2010","unstructured":"Amante DJ, Kim J, Carreiro ST, Cooper AC, Jones SW, Li T, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Ferrante RJ, Rusche J (2010) Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice. Amyotroph Lateral Scler 11:520\u2013530","journal-title":"Amyotroph Lateral Scler"},{"key":"1665_CR92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(95)00063-V","volume":"676","author":"MC Dal Canto","year":"1995","unstructured":"Dal Canto MC, Gurney ME (1995) Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 676:25\u201340","journal-title":"Brain Res"},{"key":"1665_CR93","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1523\/JNEUROSCI.18-09-03241.1998","volume":"18","author":"J Kong","year":"1998","unstructured":"Kong J, Xu Z (1998) Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18:3241\u20133250","journal-title":"J Neurosci"},{"key":"1665_CR94","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","volume":"14","author":"PC Wong","year":"1995","unstructured":"Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105\u20131116","journal-title":"Neuron"},{"key":"1665_CR95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(01)00627-X","volume":"191","author":"C Bendotti","year":"2001","unstructured":"Bendotti C, Calvaresi N, Chiveri L, Prelle A, Moggio M, Braga M, Silani V, De Biasi S (2001) Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J Neurol Sci 191:25\u201333","journal-title":"J Neurol Sci"},{"key":"1665_CR96","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1471-4159.2002.01112.x","volume":"83","author":"C Jung","year":"2002","unstructured":"Jung C, Higgins CMJ, Xu Z (2002) Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J Neurochem 83:535\u2013545","journal-title":"J Neurochem"},{"key":"1665_CR97","doi-asserted-by":"crossref","first-page":"29626","DOI":"10.1074\/jbc.M203065200","volume":"277","author":"M Mattiazzi","year":"2002","unstructured":"Mattiazzi M, D\u2019Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, Manfredi G (2002) Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 277:29626\u201329633","journal-title":"J Biol Chem"},{"key":"1665_CR98","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1471-4159.2006.03619.x","volume":"96","author":"M Damiano","year":"2006","unstructured":"Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, Mattiazzi M, Flint Beal M, Manfredi G (2006) Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu\/Zn-superoxide dismutase mutant mice. J Neurochem 96:1349\u20131361","journal-title":"J Neurochem"},{"key":"1665_CR99","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1523\/JNEUROSCI.22-06-j0001.2002","volume":"22","author":"CMJ Higgins","year":"2002","unstructured":"Higgins CMJ, Jung C, Ding H, Xu Z (2002) Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J Neurosci 22:215","journal-title":"J Neurosci"},{"key":"1665_CR100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.nbd.2006.01.001","volume":"22","author":"SE Browne","year":"2006","unstructured":"Browne SE, Yang L, DiMauro J-P, Fuller SW, Licata SC, Beal MF (2006) Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis 22:599\u2013610","journal-title":"Neurobiol Dis"},{"key":"1665_CR101","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/jcbfm.2011.155","volume":"32","author":"K Miyazaki","year":"2012","unstructured":"Miyazaki K, Masamoto K, Morimoto N, Kurata T, Mimoto T, Obata T, Kanno I, Abe K (2012) Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice. J Cereb Blood Flow Metab 32:456\u2013467","journal-title":"J Cereb Blood Flow Metab"},{"key":"1665_CR102","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1096\/fj.02-1182fje","volume":"17","author":"L Dupuis","year":"2003","unstructured":"Dupuis L, di Scala F, Rene F, de Tapia M, Oudart H, Pradat P-F, Meininger V, Loeffler J-P (2003) Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis. FASEB J 17:2091\u20132093","journal-title":"FASEB J"},{"key":"1665_CR103","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0960-8966(01)00240-1","volume":"11","author":"N Leclerc","year":"2001","unstructured":"Leclerc N, Ribera F, Zoll J, Warter JM, Poindron P, Lampert E, Borg J (2001) Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice. Neuromuscul disord 11:722\u2013727","journal-title":"Neuromuscul disord"},{"key":"1665_CR104","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1194\/jlr.M700017-JLR200","volume":"48","author":"A Fergani","year":"2007","unstructured":"Fergani A, Oudart H, Gonzalez De Aguilar J-L, Fricker B, Rene F, Hocquette J-F, Meininger V, Dupuis L, Loeffler J-P (2007) Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res 48:1571\u20131580","journal-title":"J Lipid Res"},{"key":"1665_CR105","doi-asserted-by":"crossref","first-page":"e64525","DOI":"10.1371\/journal.pone.0064525","volume":"8","author":"G Hussain","year":"2013","unstructured":"Hussain G, Schmitt F, Henriques A, Lequeu T, Rene F, Bindler F, Dirrig-Grosch S, Oudart H, Palamiuc L, Metz-Boutigue M-H, Dupuis L, Marchioni E, Gonzalez De Aguilar J-L, Loeffler J-P (2013) Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury. PLoS One 8:e64525","journal-title":"PLoS One"},{"key":"1665_CR106","doi-asserted-by":"crossref","first-page":"16320","DOI":"10.1073\/pnas.1002176107","volume":"107","author":"P-M Chiang","year":"2010","unstructured":"Chiang P-M, Ling J, Jeong YH, Price DL, Aja SM, Wong PC (2010) Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci USA 107:16320\u201316324","journal-title":"Proc Natl Acad Sci USA"},{"key":"1665_CR107","doi-asserted-by":"crossref","first-page":"e71793","DOI":"10.1371\/journal.pone.0071793","volume":"8","author":"NR Stallings","year":"2013","unstructured":"Stallings NR, Puttaparthi K, Dowling KJ, Luther CM, Burns DK, Davis K, Elliott JL (2013) TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS One 8:e71793","journal-title":"PLoS One"},{"key":"1665_CR108","doi-asserted-by":"crossref","first-page":"16325","DOI":"10.1073\/pnas.1003459107","volume":"107","author":"X Shan","year":"2010","unstructured":"Shan X, Chiang P-M, Price DL, Wong PC (2010) Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci USA 107:16325\u201316330","journal-title":"Proc Natl Acad Sci USA"},{"key":"1665_CR109","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1093\/hmg\/ddt319","volume":"22","author":"W Wang","year":"2013","unstructured":"Wang W, Li L, Lin W-L, Dickson DW, Petrucelli L, Zhang T, Wang X (2013) The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet 22:4706\u20134719","journal-title":"Hum Mol Genet"},{"key":"1665_CR110","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.1523\/JNEUROSCI.1630-10.2010","volume":"30","author":"Y-F Xu","year":"2010","unstructured":"Xu Y-F, Gendron TF, Zhang Y-J, Lin W-L, D\u2019Alton S, Sheng H, Casey MC, Tong J, Knight J, Yu X, Rademakers R, Boylan K, Hutton M, McGowan E, Dickson DW, Lewis J, Petrucelli L (2010) Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 30:10851\u201310859","journal-title":"J Neurosci"},{"key":"1665_CR111","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1750-3639.2010.00413.x","volume":"20","author":"EJ Huang","year":"2010","unstructured":"Huang EJ, Zhang J, Geser F, Trojanowski JQ, Strober JB, Dickson DW, Brown RH Jr, Shapiro BE, Lomen-Hoerth C (2010) Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol (Zurich, Switzerland) 20:1069\u20131076","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"key":"1665_CR112","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1093\/hmg\/dds299","volume":"21","author":"C Huang","year":"2012","unstructured":"Huang C, Tong J, Bi F, Wu Q, Huang B, Zhou H, Xia X-G (2012) Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats. Hum Mol Genet 21:4602\u20134614","journal-title":"Hum Mol Genet"},{"key":"1665_CR113","doi-asserted-by":"crossref","first-page":"e90449","DOI":"10.1371\/journal.pone.0090449","volume":"9","author":"ND Perera","year":"2014","unstructured":"Perera ND, Sheean RK, Scott JW, Kemp BE, Horne MK, Turner BJ (2014) Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models. PLoS One 9:e90449","journal-title":"PLoS One"},{"key":"1665_CR114","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.4103\/1673-5374.143421","volume":"9","author":"Y Sui","year":"2014","unstructured":"Sui Y, Zhao Z, Liu R, Cai B, Fan D (2014) Adenosine monophosphate-activated protein kinase activation enhances embryonic neural stem cell apoptosis in a mouse model of amyotrophic lateral sclerosis. Neural Regen Res 9:1770\u20131778","journal-title":"Neural Regen Res"},{"key":"1665_CR115","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.febslet.2014.12.029","volume":"589","author":"Y-J Liu","year":"2015","unstructured":"Liu Y-J, Lee L-M, Lai H-L, Chern Y (2015) Aberrant activation of AMP-activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis. FEBS Lett 589:432\u2013439","journal-title":"FEBS Lett"},{"key":"1665_CR116","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/hmg\/ddu497","volume":"24","author":"YJ Liu","year":"2015","unstructured":"Liu YJ, Ju TC, Chen HM, Jang YS, Lee LM, Lai HL, Tai HC, Fang JM, Lin YL, Tu PH, Chern Y (2015) Activation of AMP-activated protein kinase \u03b11 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis. Hum Mol Genet 24:787\u2013801","journal-title":"Hum Mol Genet"},{"key":"1665_CR117","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13311-013-0253-y","volume":"11","author":"R Mancuso","year":"2014","unstructured":"Mancuso R, del Valle J, Modol L, Martinez A, Granado-Serrano AB, Ramirez-Nunez O, Pallas M, Portero-Otin M, Osta R, Navarro X (2014) Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurother 11:419\u2013432","journal-title":"Neurother"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1665-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-015-1665-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1665-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T03:51:53Z","timestamp":1717991513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-015-1665-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1665"],"URL":"https:\/\/doi.org\/10.1007\/s11064-015-1665-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]}}}